SMTL ID : 4ik6.1

Crystal structure of human transthyretin in complex with lumiracoxib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-tetramer

Ligands

4 x LUR: {2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid(Non-covalent)(Covalent)

LUR.1: 10 residues within 4Å: Chain A: K.15, L.17, A.108, V.121 Chain C: M.13, K.15, L.17, E.54, A.108 Ligands: LUR.3 11 PLIP interactions: 6 interactions with chain A, 5 interactions with chain C Hydrophobic interactions: A:K.15, A:L.17, A:A.108, A:V.121, A:V.121, C:K.15, C:L.17, C:A.108 Salt bridges: A:K.15, C:K.15 pi-Cation interactions: C:K.15 LUR.2: 11 residues within 4Å: Chain B: K.15, L.17, E.54, T.106, A.108, V.121 Chain D: K.15, L.17, A.108, V.121 Ligands: LUR.4 11 PLIP interactions: 5 interactions with chain B, 6 interactions with chain D Hydrophobic interactions: B:K.15, B:L.17, B:A.108, D:K.15, D:L.17, D:A.108, D:V.121, D:V.121 Hydrogen bonds: B:E.54 Salt bridges: B:K.15, D:K.15 LUR.3: 10 residues within 4Å: Chain A: M.13, K.15, L.17, E.54, A.108 Chain C: K.15, L.17, A.108, V.121 Ligands: LUR.1 11 PLIP interactions: 5 interactions with chain A, 6 interactions with chain C Hydrophobic interactions: A:K.15, A:L.17, A:A.108, C:K.15, C:L.17, C:A.108, C:V.121, C:V.121 Salt bridges: A:K.15, C:K.15 pi-Cation interactions: A:K.15 LUR.4: 11 residues within 4Å: Chain B: K.15, L.17, A.108, V.121 Chain D: K.15, L.17, E.54, T.106, A.108, V.121 Ligands: LUR.2 11 PLIP interactions: 5 interactions with chain D, 6 interactions with chain B Hydrophobic interactions: D:K.15, D:L.17, D:A.108, B:K.15, B:L.17, B:A.108, B:V.121, B:V.121 Hydrogen bonds: D:E.54 Salt bridges: D:K.15, B:K.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lima, L.M.T.R., Crystal structure of human transthyretin in complex with lumiracoxib. To be Published

Release Date

2013-01-30

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence